Carbapenemase-producing Enterobacteriaceae in Sweden 2007-2013: experiences from seven years of systematic surveillance and mandatory reporting

Carbapenemase-producing Enterobacteriaceae (CPE) are increasing worldwide, and are a major threat to healthcare systems. Recent European data support that many countries have interregional spread of CPE or an endemic situation. In Sweden mandatory laboratory reporting of CPE of both colonisation and infection has been practiced since 2007 and since 2012 also by treating physicians. Between 2007 and 2013, 94 cases of CPE were detected in Sweden, out of which 24 were considered to cause clinical infections (bloodstream infection (n=4), urinary tract infection (n=12), wound infection (n= 4), respiratory tract infection (n=2) and catheter related (n=2)).

Source: Drug Resistance Updates - May 11, 2015 Category: Drugs & Pharmacology Authors: Sonja Löfmark, Karin Sjöström, Barbro Mäkitalo, Petra Edquist, Karin Tegmark-Wisell, Christian G. Giske Source Type: research